Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

Radiology

Volumn 223, Issue 1, 2002, Pages 11-29

  Cha, Soonmee ^a   Knopp, Edmond A ^a   Johnson, Glyn ^a   Wetzel, Stephan G ^a   Litt, Andrew W ^a   Zagzag, David ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain neoplasms; Brain, MR; Lymphoma; Magnetic resonance (MR), perfusion study; State of the Art

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ANGIOGENESIS; BRAIN BLOOD VOLUME; BRAIN INJURY; BRAIN MICROCIRCULATION; BRAIN PERFUSION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; GLIOMA; HUMAN; IMAGE ANALYSIS; INTRACRANIAL PRESSURE; LYMPHOMA; MICROVASCULATURE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION NECROSIS; REVIEW; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 0036210301     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2231010594     Document Type: Review

References (109)

1. Fundamentals of tracer kinetics for radiologists
2. Cerebral blood flow, the cerebrospinal fluid, and brain metabolism
3. Functional MR imaging of capillary hemodynamics
4. Cerebral blood flow determination by rapid-sequence computed tomography: Theoretical analysis
5. Circulation times and the theory of indicator-dilution methods for determining blood flow and volume
6. Measurement of rat brain perfusion by NMR using spin labeling of arterial water: In vivo determination of the degree of spin labeling
7. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency
8. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping
9. Perfusion imaging
10. MR perfusion imaging in human brain using the UNFAIR technique: Un-inverted flow-sensitive alternating inversion recovery
11. Multicompartment analysis of blood flow and tissue perfusion employing D20 as a freely diffusible tracer: A novel deuterium NMR technique demonstrated via application with murine RIF-1 tumors
12. Nuclear magnetic resonance studies of histone IV solution conformation
13. Effect of magnetization transfer on the measurement of cerebral blood flow using steady-state arterial spin tagging approaches: A theoretical investigation
14. Fluorocarbon-23 measure of cat cerebral blood flow by nuclear magnetic resonance
15. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects
16. Perfusion imaging with NMR contrast agents
17. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts
18. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
19. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histologic grade
20. Comparison of inversion recovery asymmetrical spin-echo EPI and gradient-echo EPI for brain motor activation study
21. Asymmetric spin-echo imaging of magnetically inhomogeneous systems: Theory, experiment, and numerical studies
22. Some considerations concerning susceptibility, longitudinal relaxation time constants and motion artifacts in vivo human spectroscopy
23. Microscopic susceptibility variation and transverse relaxation: Theory and experiment
24. Dynamic susceptibility contrast MR imaging: Correlation of signal intensity changes with cerebral blood volume measurements
25. Multi-planar image formation using NMR spin echoes
26. The limitations of NMR recalled-echo imaging techniques
27. Echo-planar imaging
28. Echo-planar MR imaging
29. Regional relative blood volume MR maps of meningiomas before and after partial embolization
30. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings
31. Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging
32. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin
33. Perfusion-sensitive MRI of cerebral lymphomas: A preliminary report
34. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors
35. The brain: Tumors
36. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas
37. Seminars in medicine of the Beth Israel Hospital, Boston: Clinical applications of research on angiogenesis
38. Angiostatin: A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth
39. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
40. Angiostatin suppresses malignant glioma growth in vivo
41. Suppression of tumor growth with recombinant murine angiostatin
42. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
43. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy
44. Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy
45. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors
46. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
47. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas
48. Proton MR spectroscopy of common brain tumors
49. Clinical applications of proton MR spectroscopy
50. Human brain tumors: Assessment with in vivo proton MR spectroscopy
51. Proton magnetic spectroscopy and intracranial tumors: Clinical perspectives
52. Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens
53. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications
54. Malignant astrocytic neoplasms: Classification, pathology, anatomy, and response to therapy
55. Angiogenesis in brain tumors: Pathobiological and clinical aspects
56. Vascular morphology and angiogenesis in glial tumors
57. The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption
58. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: Toxicity and MR findings
59. Accuracy of cytologic diagnosis of central nervous system neoplasms in stereotactic biopsies
60. CT-guided stereotactic biopsy of intracranial lesions: Correlation between core biopsy and aspiration smear
61. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms
62. Radiation injury of the brain
63. Brain radiation lesions: MR imaging
64. Late radiation necrosis of the brain: Case report
65. Late radiation injury to the temporal lobes: Morphologic evaluation at MR imaging
66. Temporal lobe necrosis in nasopharyngeal carcinoma: Pictorial essay
67. The morphologic effects of radiation administered therapeutically for intracranial gliomas: A postmortem study of 25 cases
68. Delayed cerebral radiation necrosis
69. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies
70. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET
71. The use of PET in evaluating patients with primary brain tumours: Is it useful?
72. Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography?
73. Bilateral temporal lobe necrosis after radiotherapy: Confounding SPECT results
74. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy
75. Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT
76. The role of contrast-enhanced perfusion MR imaging in differentiating between recurrent tumor and radiation necrosis
77. Gliomatosis cerebri: Clinical and histological findings
78. Gliomatosis cerebri
79. Gliomatosis cerebri: Clinical, radiological and pathological report of a case with a stroke-like onset
80. Gliomatosis cerebri: MRI, SPECT and the study of pathology
81. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: Appearance mimicking leptomeningeal tumor dissemination
82. Magnetic resonance imaging determination of gliomatosis cerebri
83. Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri
84. Capillary ultrastructure in human metastatic brain tumors
85. Vascular permeability factor in brain metastases: Correlation with vasogenic brain edema and tumor angiogenesis
86. Peritumoral region: Differentiation between primary high-grade neoplasms and solitary metastasis using dynamic contrast-enhanced T2*-weighted echo-planar perfusion MR imaging
87. Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts
88. Increasing incidence of primary brain lymphoma in the US
89. Epidemiology of primary CNS lymphoma
90. Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma
91. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus: Ten years of treatment experience at the University of California San Francisco
92. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
93. Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR imaging experience in 13 patients
94. Dynamic contrast enhanced T2*-weighted echo-planar perfusion MR imaging of primary CNS lymphoma and glioblastoma multiforme
95. Demyelinating disease versus tumor in surgical neuropathology: Clues to a correct pathological diagnosis
96. Multiple sclerosis mimicking primary brain tumor
97. Multiple sclerosis masquerading as a mass lesion
98. Demyelinating diseases
99. Large focal tumor-like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients
100. Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy
101. MR imaging of multiple sclerosis simulating brain tumor
102. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions
103. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging
104. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. II. Experimental comparison and preliminary results
105. Systematic review of diffusion and perfusion imaging in acute ischemic stroke
106. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke
107. Clinical application of perfusion and diffusion MR imaging in acute ischemic stroke
108. Clinical applications of intracranial perfusion MR imaging
109. Magnetic resonance imaging in acute stroke: Not ready for prime time